360 Health-related quality of life in patients with FRα positive platinum-resistant ovarian cancer treated with mirvetuximab soravtansine vs. investigator’s choice chemotherapy: analysis from the phase 3 MIRASOL trial
Yolanda García, T. Gorp, Gottfried E Konecny, Alexandra Leary, Alessandro D Santin, Shanthini M. Crusz, Gina Mantia-Smaldone, Domenica Lorusso, N. Colombo, J. Thomes-Pepin, Andrzej Roszak, P. Ottevanger, Mario Beiner, David Cibula, Charles Leath, Lingling Li, Michael Method, Kathleen N Moore
{"title":"360 Health-related quality of life in patients with FRα positive platinum-resistant ovarian cancer treated with mirvetuximab soravtansine vs. investigator’s choice chemotherapy: analysis from the phase 3 MIRASOL trial","authors":"Yolanda García, T. Gorp, Gottfried E Konecny, Alexandra Leary, Alessandro D Santin, Shanthini M. Crusz, Gina Mantia-Smaldone, Domenica Lorusso, N. Colombo, J. Thomes-Pepin, Andrzej Roszak, P. Ottevanger, Mario Beiner, David Cibula, Charles Leath, Lingling Li, Michael Method, Kathleen N Moore","doi":"10.1136/ijgc-2024-esgo.43","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":517822,"journal":{"name":"Oral Sessions","volume":"412 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral Sessions","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ijgc-2024-esgo.43","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
